STOCK TITAN

PACS Group, Inc. (PACS) director Evelyn Dilsaver awarded 4,660 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. director Evelyn S. Dilsaver received a grant of 4,660 restricted stock units (RSUs) of Common Stock. The award was granted at no cash price per share as equity compensation.

Each RSU converts into one share upon vesting, and 100% of the RSUs will vest on the earlier of June 10, 2027 or the next annual meeting following the grant date, subject to her continued service. Following this grant, she directly holds 31,798 shares.

Positive

  • None.

Negative

  • None.
Insider Dilsaver Evelyn S
Role null
Type Security Shares Price Value
Grant/Award Common Stock 4,660 $0.00 --
Holdings After Transaction: Common Stock — 31,798 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 4,660 RSUs Equity award to director on June 10, 2026
RSU vesting date June 10, 2027 100% vesting or earlier next annual meeting
Post-grant holdings 31,798 shares Common Stock directly held after transaction
Grant price $0.00 per share RSU award, non-cash equity compensation
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vesting financial
"one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting financial
"on the earlier to occur of (i) June 10, 2027 and (ii) the date of the next annual meeting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dilsaver Evelyn S

(Last)(First)(Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026A4,660(1)A$031,798D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) June 10, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.
Remarks:
/s/ John Mitchell, Attorney-in-Fact06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PACS director Evelyn Dilsaver report on this Form 4 for PACS?

Director Evelyn S. Dilsaver reported receiving 4,660 restricted stock units (RSUs) of PACS Group, Inc. Common Stock as an equity award. The units were granted at no cash price and are part of her director compensation rather than an open-market purchase.

How many PACS Group (PACS) RSUs were granted and what do they convert into?

The filing shows a grant of 4,660 restricted stock units (RSUs) tied to PACS Group, Inc. Common Stock. Each RSU entitles her to receive one share of Common Stock when it vests, making the award directly linked to the company’s equity.

When do Evelyn Dilsaver’s PACS Group (PACS) RSUs vest according to the Form 4?

All 4,660 RSUs vest 100% on the earlier of June 10, 2027 or the date of the next annual meeting after the grant. Vesting is conditioned on her continued service to PACS Group, Inc. through that vesting date.

Did PACS director Evelyn Dilsaver buy PACS (PACS) shares on the open market?

No, the Form 4 reports a grant of 4,660 RSUs with a transaction price of $0.00 per share. This indicates an equity award as compensation rather than an open-market purchase of PACS Group, Inc. stock.

What are Evelyn Dilsaver’s PACS Group (PACS) holdings after this RSU grant?

After the reported RSU grant, Evelyn S. Dilsaver directly holds 31,798 shares of PACS Group, Inc. Common Stock. This figure reflects her position following the award described in the Form 4 filing.

What service condition applies to the PACS (PACS) RSUs granted to Evelyn Dilsaver?

The 4,660 RSUs granted to Evelyn S. Dilsaver will vest only if she continues serving PACS Group, Inc. through the vesting date. The footnote specifies vesting is “subject to the Reporting Person's continued service to the Issuer.”